Midline carcinoma with t(15;19) and BRD4-NUT fusion oncogene in a 30-year-old female with response to docetaxel and radiotherapy

BACKGROUND: Poorly differentiated midline carcinoma with a translocation between chromosomes 15 and 19, i.e. t(15;19), has been recognized as a distinct clinical entity for over a decade. This tumor affects young individuals, shows a rapidly fatal clinical course despite intensive therapy. The t(15;...

Descripción completa

Detalles Bibliográficos
Autores principales: Engleson, Jens, Soller, Maria, Panagopoulos, Ioannis, Dahlén, Anna, Dictor, Michael, Jerkeman, Mats
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1456975/
https://www.ncbi.nlm.nih.gov/pubmed/16542442
http://dx.doi.org/10.1186/1471-2407-6-69

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1456975/
https://www.ncbi.nlm.nih.gov/pubmed/16542442
http://dx.doi.org/10.1186/1471-2407-6-69

Ejemplares similares